IVERMECTIN

IVERMECTIN was reported 4537 times

These side effects are most commonly reported by patients taking IVERMECTIN:

# Side effect Count
0 DRUG INEFFECTIVE 819
1 HEADACHE 653
2 ASTHENIA 592
3 OFF LABEL USE 512
4 PYREXIA 486
5 PRODUCT USE IN UNAPPROVED INDICATION 481
6 PRURITUS 393
7 DIARRHOEA 295
8 OCULAR HYPERAEMIA 258
9 COMA 247
10 ERYTHEMA 239
11 CONJUNCTIVAL HAEMORRHAGE 237
12 BACK PAIN 232
13 VERTIGO 218
14 ARTHRALGIA 214
15 RASH 208
16 VOMITING 204
17 FATIGUE 182
18 GAIT DISTURBANCE 168
19 NAUSEA 168
20 PAIN 168
21 ROSACEA 162
22 CONDITION AGGRAVATED 151
23 ENCEPHALOPATHY 147
24 DYSPNOEA 137
25 URINARY INCONTINENCE 136
26 MYALGIA 132
27 HYPOTENSION 129
28 STRONGYLOIDIASIS 125
29 DEPRESSED LEVEL OF CONSCIOUSNESS 123
30 SKIN BURNING SENSATION 123
31 DIZZINESS 119
32 COVID-19 110
33 DEATH 105
34 CHILLS 103
35 LOSS OF CONSCIOUSNESS 100
36 ABDOMINAL PAIN 96
37 DRY SKIN 96
38 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 95
39 PRODUCT USE ISSUE 94
40 DRUG INTERACTION 93
41 CONFUSIONAL STATE 91
42 WEIGHT DECREASED 87
43 SKIN IRRITATION 85
44 PNEUMONIA 84
45 COUGH 78
46 INTENTIONAL PRODUCT MISUSE 78
47 ACUTE KIDNEY INJURY 77
48 OVERDOSE 77
49 SKIN EXFOLIATION 77
50 ABNORMAL BEHAVIOUR 76
51 AGITATION 75
52 NO ADVERSE EVENT 75
53 ALOPECIA 72
54 SOMNOLENCE 70
55 VISION BLURRED 70
56 MALAISE 68
57 TOXICITY TO VARIOUS AGENTS 67
58 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66
59 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66
60 ADVERSE EVENT 64
61 INSOMNIA 64
62 PRODUCT DOSE OMISSION ISSUE 64
63 INTENTIONAL PRODUCT USE ISSUE 63
64 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63
65 RESPIRATORY FAILURE 62
66 HYPERSENSITIVITY 61
67 RASH PAPULAR 61
68 SWELLING FACE 61
69 PARAESTHESIA 60
70 RENAL FAILURE 60
71 URTICARIA 60
72 ABDOMINAL PAIN UPPER 59
73 MALARIA 59
74 HEPATIC CYTOLYSIS 58
75 PRODUCT PRESCRIBING ISSUE 58
76 SEPSIS 58
77 URINARY TRACT INFECTION 58
78 OEDEMA PERIPHERAL 57
79 PAIN OF SKIN 57
80 SEPTIC SHOCK 57
81 DECREASED APPETITE 56
82 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 56
83 HEART RATE INCREASED 54
84 APHASIA 53
85 ANXIETY 52
86 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 51
87 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50
88 EOSINOPHILIA 50
89 THROMBOCYTOPENIA 50
90 TREMOR 49
91 FALL 48
92 NECK PAIN 48
93 SEIZURE 48
94 WHITE BLOOD CELL COUNT DECREASED 48
95 ANAEMIA 47
96 DISORIENTATION 47
97 PAIN IN EXTREMITY 47
98 DEHYDRATION 46
99 CHEST PAIN 45
100 NEUROTOXICITY 45
101 SPEECH DISORDER 45
102 DEPRESSION 44
103 DERMATITIS 42
104 DRY MOUTH 42
105 FLUSHING 42
106 HYPERTENSION 42
107 TREATMENT FAILURE 42
108 ACNE 41
109 ANOREXIA 41
110 MUSCLE SPASMS 41
111 RASH ERYTHEMATOUS 41
112 CONSTIPATION 40
113 FEELING ABNORMAL 40
114 HOT FLUSH 39
115 RASH PRURITIC 39
116 ILLNESS 38
117 INJECTION SITE PAIN 38
118 LOGORRHOEA 38
119 TOXIC EPIDERMAL NECROLYSIS 38
120 ALANINE AMINOTRANSFERASE INCREASED 37
121 DRUG ADMINISTRATION ERROR 37
122 NERVOUS SYSTEM DISORDER 37
123 NEUTROPENIA 37
124 BLOOD PRESSURE INCREASED 36
125 CHRONIC KIDNEY DISEASE 36
126 BLISTER 35
127 DYSSTASIA 35
128 EXPRESSIVE LANGUAGE DISORDER 35
129 HEPATOCELLULAR INJURY 35
130 PERIPHERAL SWELLING 35
131 DERMATITIS CONTACT 34
132 EYE PAIN 34
133 MUSCULOSKELETAL STIFFNESS 34
134 RASH MACULO-PAPULAR 34
135 SELF-MEDICATION 34
136 VISUAL IMPAIRMENT 34
137 ALTERED STATE OF CONSCIOUSNESS 33
138 FAECAL INCONTINENCE 33
139 HYPOAESTHESIA 33
140 INFECTION 33
141 MENTAL STATUS CHANGES 33
142 STEVENS-JOHNSON SYNDROME 33
143 ACARODERMATITIS 32
144 DERMATITIS ATOPIC 32
145 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 32
146 PRODUCT QUALITY ISSUE 32
147 BALANCE DISORDER 31
148 INFLUENZA 31
149 THERAPY NON-RESPONDER 31
150 ASPARTATE AMINOTRANSFERASE INCREASED 30
151 DERMATITIS ALLERGIC 30
152 INCORRECT DOSE ADMINISTERED 30
153 SKIN DISORDER 30
154 THERAPEUTIC RESPONSE UNEXPECTED 30
155 BURNING SENSATION 29
156 ECZEMA 29
157 EYELID OEDEMA 29
158 MUSCULAR WEAKNESS 29
159 PALPITATIONS 29
160 PLATELET COUNT DECREASED 29
161 PSORIASIS 29
162 ASTHMA 28
163 CARDIAC FAILURE 28
164 EXPIRED PRODUCT ADMINISTERED 28
165 RASH MACULAR 28
166 SINUSITIS 28
167 TACHYCARDIA 28
168 ABDOMINAL DISCOMFORT 27
169 ABDOMINAL DISTENSION 27
170 DYSPHAGIA 27
171 EYE IRRITATION 27
172 LIP SWELLING 27
173 MIXED LIVER INJURY 27
174 WEIGHT INCREASED 27
175 FEELING HOT 26
176 GENERAL PHYSICAL HEALTH DETERIORATION 26
177 LIVER DISORDER 26
178 RHINOCEREBRAL MUCORMYCOSIS 26
179 ACUTE RESPIRATORY DISTRESS SYNDROME 25
180 APPLICATION SITE ERYTHEMA 25
181 CHROMATURIA 25
182 EMOTIONAL DISTRESS 25
183 INCORRECT DRUG ADMINISTRATION DURATION 25
184 INFLAMMATION 25
185 INTENTIONAL OVERDOSE 25
186 METHAEMOGLOBINAEMIA 25
187 NASOPHARYNGITIS 25
188 OROPHARYNGEAL PAIN 25
189 RED BLOOD CELL COUNT DECREASED 25
190 DISSEMINATED STRONGYLOIDIASIS 24
191 DRUG HYPERSENSITIVITY 24
192 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 24
193 LUNG DISORDER 24
194 SKIN DISCOLOURATION 24
195 SWOLLEN TONGUE 24
196 SYNCOPE 24
197 URINARY RETENTION 24
198 ABNORMAL FAECES 23
199 DECUBITUS ULCER 23
200 DRUG INTOLERANCE 23
201 EYE SWELLING 23
202 GASTROINTESTINAL DISORDER 23
203 HEPATIC FAILURE 23
204 LICE INFESTATION 23
205 MUSCULOSKELETAL DISCOMFORT 23
206 ACUTE RESPIRATORY FAILURE 22
207 BLOOD PRESSURE ABNORMAL 22
208 DYSPHONIA 22
209 MEMORY IMPAIRMENT 22
210 PANCYTOPENIA 22
211 STUPOR 22
212 APPLICATION SITE PAIN 21
213 ASCITES 21
214 EAR INFECTION 21
215 GASTROINTESTINAL HAEMORRHAGE 21
216 GASTROINTESTINAL MOTILITY DISORDER 21
217 ORAL DISCOMFORT 21
218 RENAL IMPAIRMENT 21
219 SOMATIC DELUSION 21
220 AGRANULOCYTOSIS 20
221 CANDIDA INFECTION 20
222 CARDIAC ARREST 20
223 DELIRIUM 20
224 DISEASE PROGRESSION 20
225 HEPATITIS 20
226 MATERNAL EXPOSURE DURING PREGNANCY 20
227 OEDEMA 20
228 RHINORRHOEA 20
229 SKIN LESION 20
230 ABASIA 19
231 ACCIDENTAL EXPOSURE TO PRODUCT 19
232 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19
233 BLOOD CREATININE INCREASED 19
234 BLOOD PRESSURE DECREASED 19
235 BRONCHOPULMONARY ASPERGILLOSIS 19
236 CARDIO-RESPIRATORY ARREST 19
237 CELLULITIS 19
238 CHEST DISCOMFORT 19
239 DISCOMFORT 19
240 FEELING COLD 19
241 JOINT SWELLING 19
242 PERIPHERAL COLDNESS 19
243 PRODUCTIVE COUGH 19
244 TOXIC ENCEPHALOPATHY 19
245 URINE ODOUR ABNORMAL 19
246 ADVERSE DRUG REACTION 18
247 BLINDNESS 18
248 BRADYCARDIA 18
249 DRY EYE 18
250 FORMICATION 18
251 HYPERHIDROSIS 18
252 HYPOXIA 18
253 INFECTION PARASITIC 18
254 IRRITABILITY 18
255 NUCHAL RIGIDITY 18
256 SLEEP DISORDER 18
257 AMNESIA 17
258 ARTHRITIS 17
259 ATRIAL FIBRILLATION 17
260 CHOLESTASIS 17
261 CONJUNCTIVITIS 17
262 COVID-19 PNEUMONIA 17
263 DISEASE RECURRENCE 17
264 DYSPEPSIA 17
265 EXPOSURE DURING PREGNANCY 17
266 FACE OEDEMA 17
267 HALLUCINATION 17
268 HEPATIC ENZYME INCREASED 17
269 HEPATIC FUNCTION ABNORMAL 17
270 NEUROPATHY PERIPHERAL 17
271 OXYGEN SATURATION DECREASED 17
272 PRODUCT AVAILABILITY ISSUE 17
273 PRURITUS GENERALISED 17
274 SCAB 17
275 THERAPEUTIC RESPONSE DECREASED 17
276 BLOOD ALKALINE PHOSPHATASE INCREASED 16
277 COLITIS 16
278 CONTUSION 16
279 DRUG-INDUCED LIVER INJURY 16
280 EYE PRURITUS 16
281 GASTROOESOPHAGEAL REFLUX DISEASE 16
282 HAEMOGLOBIN DECREASED 16
283 HYPOGLYCAEMIA 16
284 MENTAL DISORDER 16
285 MULTI-ORGAN FAILURE 16
286 PUSTULE 16
287 SUICIDAL IDEATION 16
288 SWELLING 16
289 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16
290 APPLICATION SITE PRURITUS 15
291 CONJUNCTIVAL HYPERAEMIA 15
292 ELECTROCARDIOGRAM QT PROLONGED 15
293 EPISTAXIS 15
294 FUNGAL INFECTION 15
295 PSORIATIC ARTHROPATHY 15
296 PULMONARY EMBOLISM 15
297 RESPIRATORY DISORDER 15
298 RESPIRATORY DISTRESS 15
299 SURGERY 15
300 UNDERDOSE 15
301 UPPER RESPIRATORY TRACT INFECTION 15
302 ACCIDENTAL OVERDOSE 14
303 ANAPHYLACTIC REACTION 14
304 ANHEDONIA 14
305 BLOOD GLUCOSE INCREASED 14
306 CEREBROVASCULAR ACCIDENT 14
307 GAIT INABILITY 14
308 GASTRITIS EROSIVE 14
309 LACRIMATION INCREASED 14
310 LYMPHADENOPATHY 14
311 MALIGNANT NEOPLASM PROGRESSION 14
312 MIGRAINE 14
313 PEMPHIGOID 14
314 SHOCK HAEMORRHAGIC 14
315 SKIN REACTION 14
316 THERAPY INTERRUPTED 14
317 WHITE BLOOD CELL COUNT INCREASED 14
318 ANGIOEDEMA 13
319 ATAXIA 13
320 CHEILITIS 13
321 DERMATITIS BULLOUS 13
322 DISSEMINATED INTRAVASCULAR COAGULATION 13
323 DRUG ERUPTION 13
324 DYSARTHRIA 13
325 DYSGEUSIA 13
326 EATING DISORDER 13
327 EOSINOPHIL COUNT INCREASED 13
328 ESCHERICHIA INFECTION 13
329 FLATULENCE 13
330 FOETAL EXPOSURE DURING PREGNANCY 13
331 GENERALISED OEDEMA 13
332 HAEMATOCHEZIA 13
333 HERPES ZOSTER 13
334 HYPERAMMONAEMIA 13
335 ILEUS 13
336 IMPAIRED QUALITY OF LIFE 13
337 INCONTINENCE 13
338 INJECTION SITE ERYTHEMA 13
339 INTENTIONAL DOSE OMISSION 13
340 INTENTIONAL UNDERDOSE 13
341 JAUNDICE 13
342 LETHARGY 13
343 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13
344 METABOLIC ACIDOSIS 13
345 MOBILITY DECREASED 13
346 OSTEOPOROSIS 13
347 PRODUCT ODOUR ABNORMAL 13
348 RASH PUSTULAR 13
349 STRESS 13
350 ABDOMINAL PAIN LOWER 12
351 ARRHYTHMIA 12
352 BONE PAIN 12
353 CONVULSION 12
354 CYTOMEGALOVIRUS INFECTION 12
355 DIABETES MELLITUS 12
356 DRUG RESISTANCE 12
357 INFLUENZA LIKE ILLNESS 12
358 MYOCARDIAL INFARCTION 12
359 ORTHOSTATIC HYPOTENSION 12
360 PNEUMONIA ASPIRATION 12
361 RENAL FAILURE ACUTE 12
362 SECRETION DISCHARGE 12
363 SKIN HYPERPIGMENTATION 12
364 SKIN SWELLING 12
365 STAPHYLOCOCCAL INFECTION 12
366 TINNITUS 12
367 UNRESPONSIVE TO STIMULI 12
368 WHEEZING 12
369 APATHY 11
370 BLOOD BILIRUBIN INCREASED 11
371 BRONCHITIS 11
372 DIPLOPIA 11
373 ENTEROCOCCAL INFECTION 11
374 FEBRILE NEUTROPENIA 11
375 HEAD DISCOMFORT 11
376 HYPONATRAEMIA 11
377 ILL-DEFINED DISORDER 11
378 LACTIC ACIDOSIS 11
379 NASAL CONGESTION 11
380 PARESIS 11
381 PETECHIAE 11
382 PHOTOPHOBIA 11
383 PRESCRIBED OVERDOSE 11
384 PRODUCT DOSE OMISSION IN ERROR 11
385 PRODUCT PRESCRIBING ERROR 11
386 PSYCHOMOTOR HYPERACTIVITY 11
387 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11
388 SUICIDE ATTEMPT 11
389 TACHYPNOEA 11
390 VASCULITIS 11
391 AGGRESSION 10
392 APLASIA PURE RED CELL 10
393 BACTERAEMIA 10
394 BODY TEMPERATURE INCREASED 10
395 CARDIAC DISORDER 10
396 CATARACT 10
397 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10
398 DRUG DOSE OMISSION 10
399 EYE DISORDER 10
400 GASTRITIS 10
401 HAEMATURIA 10
402 HAEMORRHAGE 10
403 HEPATOTOXICITY 10
404 HOSPITALISATION 10
405 HYPERKALAEMIA 10
406 HYPERSOMNIA 10
407 JOINT STIFFNESS 10
408 MONOPARESIS 10
409 MULTIPLE USE OF SINGLE-USE PRODUCT 10
410 MUSCULOSKELETAL CHEST PAIN 10
411 NEPHROLITHIASIS 10
412 OCULAR DISCOMFORT 10
413 OSTEOPENIA 10
414 PLEURAL EFFUSION 10
415 PNEUMONITIS 10
416 PRODUCT SUBSTITUTION ISSUE 10
417 RHEUMATOID ARTHRITIS 10
418 SHOCK 10
419 SKIN HAEMORRHAGE 10
420 SKIN ULCER 10
421 THERAPEUTIC RESPONSE SHORTENED 10
422 THROAT IRRITATION 10
423 THROMBOSIS 10
424 TREATMENT NONCOMPLIANCE 10
425 UNEVALUABLE EVENT 10
426 APPLICATION SITE IRRITATION 9
427 APPLICATION SITE SWELLING 9
428 BLOOD CHOLESTEROL INCREASED 9
429 CLOSTRIDIUM DIFFICILE COLITIS 9
430 DEEP VEIN THROMBOSIS 9
431 DIFFICULTY IN WALKING 9
432 ELECTROLYTE IMBALANCE 9
433 ENCEPHALITIS 9
434 EXTRA DOSE ADMINISTERED 9
435 FAECES DISCOLOURED 9
436 FILARIASIS 9
437 HAEMOPTYSIS 9
438 HAIR DISORDER 9
439 HEPATOMEGALY 9
440 HYPERBILIRUBINAEMIA 9
441 HYPERGLYCAEMIA 9
442 IMMUNE SYSTEM DISORDER 9
443 INCOHERENT 9
444 INJECTION SITE BRUISING 9
445 KLEBSIELLA INFECTION 9
446 LOCALISED OEDEMA 9
447 MALNUTRITION 9
448 MAZZOTTI REACTION 9
449 MELAENA 9
450 MENINGITIS 9
451 NEMATODIASIS 9
452 PAIN IN JAW 9
453 PALLOR 9
454 PANCREATITIS 9
455 PHOTOSENSITIVITY REACTION 9
456 POISONING DELIBERATE 9
457 PRODUCT PHYSICAL CONSISTENCY ISSUE 9
458 PURPURA 9
459 SCAR 9
460 SKIN TIGHTNESS 9
461 SKIN WARM 9
462 STOMATITIS 9
463 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9
464 VISUAL ACUITY REDUCED 9
465 ACUTE HEPATIC FAILURE 8
466 ANAPHYLACTIC SHOCK 8
467 APPLICATION SITE RASH 8
468 BRAIN FOG 8
469 C-REACTIVE PROTEIN INCREASED 8
470 CHORIORETINOPATHY 8
471 CIRCULATORY COLLAPSE 8
472 COAGULOPATHY 8
473 COMA SCALE ABNORMAL 8
474 CRYING 8
475 CYSTITIS 8
476 CYTOKINE RELEASE SYNDROME 8
477 CYTOLYTIC HEPATITIS 8
478 DERMATITIS EXFOLIATIVE 8
479 DISABILITY 8
480 DRUG EFFECT DECREASED 8
481 DYSPNOEA EXERTIONAL 8
482 FUNGAEMIA 8
483 HYPERSENSITIVITY VASCULITIS 8
484 HYPOKALAEMIA 8
485 INCORRECT ROUTE OF DRUG ADMINISTRATION 8
486 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8
487 INFUSION RELATED REACTION 8
488 INSURANCE ISSUE 8
489 INTESTINAL OBSTRUCTION 8
490 LEUKOPENIA 8
491 LIVER FUNCTION TEST INCREASED 8
492 MUSCLE TWITCHING 8
493 MYELOSUPPRESSION 8
494 NEOPLASM MALIGNANT 8
495 ORAL HERPES 8
496 PAPULE 8
497 PARALYSIS 8
498 POLYARTHRITIS 8
499 PRESYNCOPE 8
500 PULSE ABNORMAL 8
501 SCRATCH 8
502 SEASONAL ALLERGY 8
503 SINUSITIS FUNGAL 8
504 SMALL INTESTINAL OBSTRUCTION 8
505 THROAT TIGHTNESS 8
506 TRANSAMINASES INCREASED 8
507 ABORTION SPONTANEOUS 7
508 ACIDOSIS 7
509 APPLICATION SITE DRYNESS 7
510 AUTOIMMUNE HEPATITIS 7
511 BACTERIAL INFECTION 7
512 CEREBRAL DISORDER 7
513 CEREBRAL HAEMORRHAGE 7
514 CEREBRAL INFARCTION 7
515 DANDRUFF 7
516 DRUG EXPOSURE DURING PREGNANCY 7
517 DRY THROAT 7
518 DUODENAL ULCER 7
519 ECONOMIC PROBLEM 7
520 END STAGE RENAL DISEASE 7
521 ERECTILE DYSFUNCTION 7
522 ERUCTATION 7
523 ERYTHEMA MULTIFORME 7
524 ESCHERICHIA BACTERAEMIA 7
525 EYE DISCHARGE 7
526 FEEDING DISORDER 7
527 HAEMATEMESIS 7
528 HALLUCINATION, VISUAL 7
529 HEART RATE DECREASED 7
530 HEMIPLEGIA 7
531 HERPES SIMPLEX 7
532 HYPERCALCAEMIA 7
533 HYPERTHERMIA 7
534 INCORRECT PRODUCT ADMINISTRATION DURATION 7
535 INFESTATION 7
536 INFUSION SITE PAIN 7
537 INJECTION SITE MASS 7
538 INTERSTITIAL LUNG DISEASE 7
539 JOINT RANGE OF MOTION DECREASED 7
540 LEUKOCYTOSIS 7
541 LICHENOID KERATOSIS 7
542 LYMPHOPENIA 7
543 MOOD ALTERED 7
544 MOUTH ULCERATION 7
545 MUCOSAL INFLAMMATION 7
546 MUTISM 7
547 NIGHT SWEATS 7
548 OSTEOARTHRITIS 7
549 PHARYNGEAL OEDEMA 7
550 PHOTOPSIA 7
551 POISONING 7
552 PSEUDOMONAL SEPSIS 7
553 RESPIRATORY ARREST 7
554 RHABDOMYOLYSIS 7
555 SARS-COV-2 TEST POSITIVE 7
556 SKIN DISCOMFORT 7
557 SKIN FISSURES 7
558 SUDDEN DEATH 7
559 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 7
560 THERAPY CESSATION 7
561 TORSADE DE POINTES 7
562 VASCULAR PURPURA 7
563 VISCERAL LARVA MIGRANS 7
564 VITREOUS FLOATERS 7
565 ANURIA 6
566 APHONIA 6
567 APPLICATION SITE BURN 6
568 APPLICATION SITE EXFOLIATION 6
569 ARTHROPOD BITE 6
570 ATELECTASIS 6
571 BACTERIAL SEPSIS 6
572 BLOOD CREATINE PHOSPHOKINASE INCREASED 6
573 BLOOD DISORDER 6
574 BLOOD POTASSIUM DECREASED 6
575 BLOOD SMEAR TEST ABNORMAL 6
576 BONE DENSITY DECREASED 6
577 CARDIAC MURMUR 6
578 CYST 6
579 CYTOMEGALOVIRUS INFECTION REACTIVATION 6
580 DIARRHOEA HAEMORRHAGIC 6
581 DISTURBANCE IN ATTENTION 6
582 DIVERTICULITIS 6
583 DRUG LEVEL DECREASED 6
584 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6
585 FACIAL PAIN 6
586 FOOT FRACTURE 6
587 FREQUENT BOWEL MOVEMENTS 6
588 GASTRIC DISORDER 6
589 GASTROENTERITIS 6
590 GLOMERULONEPHRITIS MEMBRANOUS 6
591 HEART RATE ABNORMAL 6
592 HELMINTHIC INFECTION 6
593 HEPATIC STEATOSIS 6
594 HEREDITARY ANGIOEDEMA 6
595 HICCUPS 6
596 HUNGER 6
597 HYPERREFLEXIA 6
598 HYPOPHAGIA 6
599 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6
600 INJECTION SITE PRURITUS 6
601 INJURY 6
602 LIMB DISCOMFORT 6
603 LIMB INJURY 6
604 LIVER FUNCTION TEST ABNORMAL 6
605 LUNG INFILTRATION 6
606 LYME DISEASE 6
607 LYMPHANGITIS 6
608 MOVEMENT DISORDER 6
609 MUCORMYCOSIS 6
610 MUSCLE FATIGUE 6
611 MYOCLONUS 6
612 NYSTAGMUS 6
613 OLIGURIA 6
614 ONYCHOMYCOSIS 6
615 ORAL DISORDER 6
616 PANCREATITIS ACUTE 6
617 PARAPARESIS 6
618 PERIORBITAL SWELLING 6
619 PHARYNGEAL SWELLING 6
620 PLASMA CELL MYELOMA 6
621 PNEUMONIA KLEBSIELLA 6
622 PRODUCT ADMINISTRATION ERROR 6
623 PRODUCT DOSE OMISSION 6
624 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6
625 PSEUDOMONAS INFECTION 6
626 PULMONARY OEDEMA 6
627 RASH GENERALISED 6
628 RENAL DISORDER 6
629 RESPIRATORY TRACT INFECTION 6
630 SCABIES 6
631 SEBORRHOEA 6
632 SKIN LACERATION 6
633 SKIN MASS 6
634 TEMPERATURE INTOLERANCE 6
635 THERAPEUTIC PRODUCT EFFECT DECREASED 6
636 THERAPY PARTIAL RESPONDER 6
637 TOOTH ABSCESS 6
638 TRANSIENT ISCHAEMIC ATTACK 6
639 TYPE 2 DIABETES MELLITUS 6
640 UROSEPSIS 6
641 VENTRICULAR ARRHYTHMIA 6
642 VIRAL INFECTION 6
643 ADVERSE REACTION 5
644 APLASTIC ANAEMIA 5
645 APPLICATION SITE INFLAMMATION 5
646 ATRIAL FLUTTER 5
647 BASAL CELL CARCINOMA 5
648 BLOOD IMMUNOGLOBULIN E INCREASED 5
649 BLOOD LACTATE DEHYDROGENASE INCREASED 5
650 BRONCHOSPASM 5
651 CENTRAL NERVOUS SYSTEM INFECTION 5
652 CERVICAL DYSPLASIA 5
653 COGNITIVE DISORDER 5
654 CREPITATIONS 5
655 CYTOPENIA 5
656 DRUG ABUSE 5
657 DRUG EFFECT INCOMPLETE 5
658 DRUG PRESCRIBING ERROR 5
659 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 5
660 ERYTHEMA OF EYELID 5
661 FEAR 5
662 FEELING DRUNK 5
663 FOOD ALLERGY 5
664 GASTROENTERITIS VIRAL 5
665 HAEMATOMA 5
666 HEAD INJURY 5
667 HEPATITIS ACUTE 5
668 HIATUS HERNIA 5
669 HOOKWORM INFECTION 5
670 HYPEREOSINOPHILIC SYNDROME 5
671 HYPERPARATHYROIDISM SECONDARY 5
672 HYPERVENTILATION 5
673 HYPOCALCAEMIA 5
674 HYPOPHOSPHATAEMIA 5
675 HYPOTHYROIDISM 5
676 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5
677 INFUSION SITE EXTRAVASATION 5
678 INTENTION TREMOR 5
679 INTERNATIONAL NORMALISED RATIO INCREASED 5
680 LOCALISED INFECTION 5
681 METASTASES TO BONE 5
682 MYDRIASIS 5
683 NAIL DISORDER 5
684 NODULE 5
685 ORAL INFECTION 5
686 ORAL PAIN 5
687 OROPHARYNGEAL DISCOMFORT 5
688 PATHOGEN RESISTANCE 5
689 PNEUMONIA BACTERIAL 5
690 POLLAKIURIA 5
691 POOR QUALITY PRODUCT ADMINISTERED 5
692 POST PROCEDURAL COMPLICATION 5
693 PRODUCT ADMINISTRATION INTERRUPTED 5
694 PULMONARY ALVEOLAR HAEMORRHAGE 5
695 PULMONARY CONGESTION 5
696 RALES 5
697 REBOUND ACID HYPERSECRETION 5
698 REBOUND EFFECT 5
699 RED BLOOD CELL COUNT INCREASED 5
700 RENAL INJURY 5
701 RESPIRATORY TRACT CONGESTION 5
702 ROAD TRAFFIC ACCIDENT 5
703 SCHISTOSOMIASIS 5
704 SCROTAL SWELLING 5
705 SEDATION 5
706 SENSITIVE SKIN 5
707 SKIN CANCER 5
708 SKIN HYPOPIGMENTATION 5
709 SLEEP APNOEA SYNDROME 5
710 SLUGGISHNESS 5
711 SQUAMOUS CELL CARCINOMA OF SKIN 5
712 SUPERINFECTION 5
713 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 5
714 TACHYARRHYTHMIA 5
715 TASTE DISORDER 5
716 TEMPOROMANDIBULAR JOINT SYNDROME 5
717 THINKING ABNORMAL 5
718 TONGUE HAEMATOMA 5
719 TOOTH DISORDER 5
720 TOOTH INFECTION 5
721 ULCER 5
722 URINARY HESITATION 5
723 VIROLOGIC FAILURE 5
724 WEIGHT FLUCTUATION 5
725 WOUND 5
726 ABNORMAL DREAMS 4
727 ABNORMAL SENSATION IN EYE 4
728 ABORTION INDUCED 4
729 ACUTE MYOCARDIAL INFARCTION 4
730 ANAL SPHINCTER ATONY 4
731 ANGER 4
732 ANOSMIA 4
733 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4
734 APPLICATION SITE REACTION 4
735 ARTHROPATHY 4
736 ASPERGILLUS INFECTION 4
737 BEDRIDDEN 4
738 BLINDNESS TRANSIENT 4
739 BLOOD SODIUM DECREASED 4
740 BODY TEMPERATURE DECREASED 4
741 BONE DISORDER 4
742 BRAIN INJURY 4
743 BRAIN OEDEMA 4
744 BRONCHIAL WALL THICKENING 4
745 BRONCHIOLITIS 4
746 BURSITIS 4
747 CARDIAC FAILURE CONGESTIVE 4
748 CEREBELLAR SYNDROME 4
749 CHOKING 4
750 COLON CANCER 4
751 CONGENITAL CARDIOVASCULAR ANOMALY 4
752 CONGENITAL MUSCLE ABSENCE 4
753 DECREASED ACTIVITY 4
754 DEMENTIA 4
755 DERMATITIS ACNEIFORM 4
756 DIABETIC KETOACIDOSIS 4
757 DRUG DEPENDENCE, ANTEPARTUM 4
758 DUODENITIS 4
759 DYSKINESIA 4
760 DYSURIA 4
761 EPILEPSY 4
762 EXTRASYSTOLES 4
763 EYE INFECTION 4
764 EYELID PTOSIS 4
765 FACIAL PARALYSIS 4
766 FIBRIN D DIMER INCREASED 4
767 FIBROMYALGIA 4
768 FOLLICULITIS 4
769 FOOD INTOLERANCE 4
770 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
771 GENERALISED ERYTHEMA 4
772 GINGIVAL BLEEDING 4
773 GLASGOW COMA SCALE ABNORMAL 4
774 GLOMERULAR FILTRATION RATE DECREASED 4
775 HAEMODYNAMIC INSTABILITY 4
776 HEART RATE IRREGULAR 4
777 HEPATIC NECROSIS 4
778 HEPATIC PAIN 4
779 HEPATITIS CHOLESTATIC 4
780 HEPATORENAL FAILURE 4
781 HERPES SIMPLEX HEPATITIS 4
782 HORDEOLUM 4
783 HYDROCEPHALUS 4
784 HYPOACUSIS 4
785 IMMUNODEFICIENCY 4
786 INCREASED APPETITE 4
787 INFLAMMATORY MARKER INCREASED 4
788 INJECTION SITE SWELLING 4
789 INJECTION SITE URTICARIA 4
790 INTERVERTEBRAL DISC DEGENERATION 4
791 INTRA-ABDOMINAL HAEMATOMA 4
792 IRRITABLE BOWEL SYNDROME 4
793 KIDNEY INFECTION 4
794 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4
795 LARGE INTESTINE PERFORATION 4
796 LIGAMENT SPRAIN 4
797 LIQUID PRODUCT PHYSICAL ISSUE 4
798 LIVEDO RETICULARIS 4
799 LOCAL SWELLING 4
800 LOWER RESPIRATORY TRACT INFECTION 4
801 LUNG OPACITY 4
802 MARASMUS 4
803 MEDICATION ERROR 4
804 MENTAL IMPAIRMENT 4
805 MULTIPLE SCLEROSIS 4
806 MUSCLE ATROPHY 4
807 MUSCLE RIGIDITY 4
808 MUSCLE TIGHTNESS 4
809 MUSCULOSKELETAL DISORDER 4
810 MYOCARDITIS 4
811 NEPHROGENIC ANAEMIA 4
812 NERVOUSNESS 4
813 NEURALGIA 4
814 NEUROPSYCHOLOGICAL SYMPTOMS 4
815 NEUTROPHIL COUNT DECREASED 4
816 OBESITY 4
817 OESOPHAGITIS 4
818 ONYCHOCLASIS 4
819 ORAL CANDIDIASIS 4
820 OSMOTIC DEMYELINATION SYNDROME 4
821 OSTEONECROSIS OF JAW 4
822 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4
823 PARADOXICAL DRUG REACTION 4
824 PARAESTHESIA ORAL 4
825 PARANASAL SINUS DISCOMFORT 4
826 PARTIAL SEIZURES 4
827 PERICARDIAL EFFUSION 4
828 PERIORAL DERMATITIS 4
829 PHARYNGITIS 4
830 PRE-EXISTING CONDITION IMPROVED 4
831 PREMATURE DELIVERY 4
832 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4
833 PRODUCT DISTRIBUTION ISSUE 4
834 PRODUCT PACKAGING QUANTITY ISSUE 4
835 PRODUCT PHYSICAL ISSUE 4
836 PRODUCT PREPARATION ERROR 4
837 PRURITUS ALLERGIC 4
838 PSYCHOTIC DISORDER 4
839 PULMONARY MASS 4
840 PULSELESS ELECTRICAL ACTIVITY 4
841 RECTAL HAEMORRHAGE 4
842 RESTLESSNESS 4
843 RHINITIS 4
844 SALIVARY HYPERSECRETION 4
845 SCOLIOSIS 4
846 SENSORY DISTURBANCE 4
847 SENSORY LOSS 4
848 SKIN WEEPING 4
849 SNEEZING 4
850 SPINAL PAIN 4
851 SPIROMETRY ABNORMAL 4
852 SUPERINFECTION BACTERIAL 4
853 SUPRAPUBIC PAIN 4
854 SWELLING OF EYELID 4
855 TENDONITIS 4
856 TESTICULAR PAIN 4
857 THIRST 4
858 THYROID FUNCTION TEST ABNORMAL 4
859 TOOTH LOSS 4
860 TOOTHACHE 4
861 TOXIC SKIN ERUPTION 4
862 UNDERWEIGHT 4
863 UPPER-AIRWAY COUGH SYNDROME 4
864 VENTRICULAR EXTRASYSTOLES 4
865 VENTRICULAR FIBRILLATION 4
866 VIRAL MUTATION IDENTIFIED 4
867 VITAMIN B12 DEFICIENCY 4
868 VITAMIN D DECREASED 4
869 VITAMIN D DEFICIENCY 4
870 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4
871 ABSCESS LIMB 3
872 ACNE CYSTIC 3
873 ACTIVITIES OF DAILY LIVING IMPAIRED 3
874 ACUTE LUNG INJURY 3
875 ACUTE PULMONARY OEDEMA 3
876 ADRENAL INSUFFICIENCY 3
877 AGEUSIA 3
878 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
879 ANAL INCONTINENCE 3
880 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 3
881 APPLICATION SITE DISCOLOURATION 3
882 ARTERIOSCLEROSIS 3
883 ASPHYXIA 3
884 AUTOIMMUNE THYROIDITIS 3
885 BACK DISORDER 3
886 BENIGN PROSTATIC HYPERPLASIA 3
887 BIFIDOBACTERIUM INFECTION 3
888 BLADDER DISTENSION 3
889 BLINDNESS UNILATERAL 3
890 BLOOD MAGNESIUM DECREASED 3
891 BLOOD TEST ABNORMAL 3
892 BLOOD TRIGLYCERIDES INCREASED 3
893 BLOOD UREA INCREASED 3
894 BODY HEIGHT DECREASED 3
895 BODY TEMPERATURE ABNORMAL 3
896 BREAST CANCER 3
897 BREAST CANCER STAGE I 3
898 CANCER PAIN 3
899 CARDIOGENIC SHOCK 3
900 CARDIOVASCULAR DISORDER 3
901 CARPAL TUNNEL SYNDROME 3
902 CENTRAL NERVOUS SYSTEM LESION 3
903 CHEMICAL BURN OF SKIN 3
904 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
905 COLD SWEAT 3
906 COMPLICATION ASSOCIATED WITH DEVICE 3
907 CONTRAINDICATED PRODUCT ADMINISTERED 3
908 CORONARY ARTERY DISEASE 3
909 CORTISOL DECREASED 3
910 CROHN^S DISEASE 3
911 CYANOSIS 3
912 DECREASED IMMUNE RESPONSIVENESS 3
913 DELUSION 3
914 DELUSION OF PARASITOSIS 3
915 DEVICE RELATED INFECTION 3
916 DIABETIC COMA 3
917 DIET REFUSAL 3
918 DIPLEGIA 3
919 DISSEMINATED TUBERCULOSIS 3
920 DRUG DEPENDENCE 3
921 DRUG EFFECT LESS THAN EXPECTED 3
922 EAR PAIN 3
923 ENDOCRINE OPHTHALMOPATHY 3
924 ENERGY INCREASED 3
925 ENTERITIS 3
926 ENURESIS 3
927 EPIGASTRIC DISCOMFORT 3
928 EROSIVE OESOPHAGITIS 3
929 ESCHERICHIA URINARY TRACT INFECTION 3
930 ESSENTIAL HYPERTENSION 3
931 EXOSTOSIS 3
932 EXPOSURE VIA SKIN CONTACT 3
933 EXTRAPYRAMIDAL DISORDER 3
934 EYE INFLAMMATION 3
935 FAECES PALE 3
936 FOETAL DEATH 3
937 FOREIGN BODY SENSATION IN EYES 3
938 FOURNIER^S GANGRENE 3
939 FULL BLOOD COUNT DECREASED 3
940 GANGRENE 3
941 GASTRIC PERFORATION 3
942 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3
943 GASTROINTESTINAL PAIN 3
944 GENERAL PHYSICAL CONDITION ABNORMAL 3
945 GENERAL SYMPTOM 3
946 GINGIVAL DISORDER 3
947 GLOSSODYNIA 3
948 GOUT 3
949 HAEMORRHOIDS 3
950 HAIR TEXTURE ABNORMAL 3
951 HAND FRACTURE 3
952 HEMIPARESIS 3
953 HENOCH-SCHONLEIN PURPURA 3
954 HEPATIC ENCEPHALOPATHY 3
955 HEPATITIS FULMINANT 3
956 HEPATITIS TOXIC 3
957 HERPES VIRUS INFECTION 3
958 HIV INFECTION 3
959 HORMONE LEVEL ABNORMAL 3
960 HYPERTONIA 3
961 HYPERTONIC BLADDER 3
962 HYPOAESTHESIA ORAL 3
963 HYPOGAMMAGLOBULINAEMIA 3
964 HYPOTHERMIA 3
965 HYPOVOLAEMIC SHOCK 3
966 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3
967 IMMUNOSUPPRESSION 3
968 IMPAIRED DRIVING ABILITY 3
969 IMPAIRED GASTRIC EMPTYING 3
970 INCORRECT DRUG ADMINISTRATION RATE 3
971 INCREASED TENDENCY TO BRUISE 3
972 INFUSION SITE HAEMORRHAGE 3
973 INTRACRANIAL INFECTION 3
974 INTRACRANIAL PRESSURE INCREASED 3
975 IRON DEFICIENCY 3
976 ISCHAEMIC HEPATITIS 3
977 ISCHAEMIC STROKE 3
978 JOINT ANKYLOSIS 3
979 KERATITIS 3
980 KNEE ARTHROPLASTY 3
981 LARGE INTESTINE POLYP 3
982 LARYNGEAL OEDEMA 3
983 LARYNGITIS 3
984 LIVER INJURY 3
985 LOCKED-IN SYNDROME 3
986 LYMPHADENITIS 3
987 MACROCEPHALY 3
988 MASS 3
989 MEGACOLON 3
990 MENINGITIS BACTERIAL 3
991 MENINGITIS VIRAL 3
992 METABOLIC ENCEPHALOPATHY 3
993 MULTIPLE ALLERGIES 3
994 MULTIPLE SCLEROSIS RELAPSE 3
995 MYCOBACTERIAL INFECTION 3
996 NECROTISING FASCIITIS 3
997 NEOPLASM PROGRESSION 3
998 NEPHROPATHY TOXIC 3
999 NERVE COMPRESSION 3